2023
DOI: 10.1111/epi.17545
|View full text |Cite
|
Sign up to set email alerts
|

A solved puzzle: Familial adult myoclonus epilepsy is a new expansion repeats disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…51 The clinical management is essentially symptomatic and based on ASMs that have both an antiseizure and an antimyoclonic effect, such as valproate, levetiracetam, benzodiazepines, and perampanel. 52 The clinical course is nonprogressive or slowly progressive: epilepsy is commonly controlled with medications and individuals have a normal life expectancy. However, the myoclonus severity increases with age and leads to some degree of disability in the elderly.…”
Section: Familial Adult Myoclonic Epilepsy (Fame)mentioning
confidence: 99%
“…51 The clinical management is essentially symptomatic and based on ASMs that have both an antiseizure and an antimyoclonic effect, such as valproate, levetiracetam, benzodiazepines, and perampanel. 52 The clinical course is nonprogressive or slowly progressive: epilepsy is commonly controlled with medications and individuals have a normal life expectancy. However, the myoclonus severity increases with age and leads to some degree of disability in the elderly.…”
Section: Familial Adult Myoclonic Epilepsy (Fame)mentioning
confidence: 99%